At a glance
- Originator Pfizer
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 05 Apr 2000 Profile reviewed but no significant changes made
- 19 Oct 1994 No-Development-Reported for Cancer in USA (Unknown route)